Results 171 to 180 of about 1,936,479 (187)
Some of the next articles are maybe not open access.
COVID-19 drugs and drug repositioning
2021Introduction: The COVID-19 pandemic is caused by SARS-CoV-2. Drug repositioning is a propitious field in the development and discovery of therapeutic agents that distinguishes new therapeutic options for existing drugs. There are repositioned drugs in COVID-19 treatment. Aim: We aimed to explore repositioned drugs for COVID-19 pharmacotherapy.
openaire +1 more source
Topological network measures for drug repositioning.
Briefings in Bioinformatics, 2021Thomas Sauter +2 more
exaly
HeTDR: Drug repositioning based on heterogeneous networks and text mining
Patterns, 2021Xiangrong Liu, Zhangming Niu, Xurui Jin
exaly
Drug repositioning based on the heterogeneous information fusion graph convolutional network.
Briefings in Bioinformatics, 2021Xiangzheng Fu, Peng Wang, Yajie Meng
exaly
A survey of current trends in computational drug repositioning.
Briefings in Bioinformatics, 2016Jiao Li, Zhiyong Lu, Atul Butte
exaly
Adaptive Drug Repositioning Prediction
2024 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)Zhenpeng Wu, Jiamin Chen, Jianliang Gao
openaire +1 more source
Old friends in new guise: repositioning of known drugs with structural bioinformatics.
Briefings in Bioinformatics, 2011Joachim Haupt +2 more
exaly
A review of validation strategies for computational drug repositioning
Briefings in Bioinformatics, 2018Adam S Brown, Chirag J Patel
exaly